← Leaderboards
Karen T. Liby
Michigan State University
$1,405,915
Attributed
$1,405,915
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $364K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,405,915 · 1
By mechanism
R01$1,405,915 · 1
Top collaborators
No co-investigators on record.
Most similar at Michigan State University
Same institution · by research overlap
- Vincent B Young$20,733,414
- Jessica Ann Moerland$67,957
- Dean Dellapenna$5,015,549
- Robert L Last$6,389,911
- Ruanbao Zhou$1,565,947
Others in their field
Other Emerging Leaders on “Cytotoxic T-Lymphocytes”
- Wilton B Williams · Duke University$11,406,665
- Deanna A Kulpa · Emory University$10,394,989
- Gaurav Das Gaiha · Massachusetts General Hospital$6,586,745
- Nilu Goonetilleke · Univ Of North Carolina Chapel Hill$6,073,977
- Michael Daniel Keller · Children'S Research Institute$4,910,377
- Todd Christopher Bradley · Children'S Mercy Hosp (Kansas City, Mo)$4,700,068
Research focus
Cytotoxic T-LymphocytesDietary ComponentAnimal ModelAreaCytokineAnti-Inflammatory AgentsArchivesCancer PatientCancer RiskCarcinogenesisCellsBeta CaroteneCessation Of LifeChemopreventionCancer EtiologyChemotherapyChronic DiseaseChronic Kidney FailureClinically RelevantClinical TreatmentClinical TrialsColon CarcinomaComparative EfficacyDietary Supplements
Grant awards (5)
Nrf2, immune cells and lung cancer$1
R01 · FY2023 · CA · contact PI
Nrf2, immune cells and lung cancer$341,213
R01 · FY2022 · CA · contact PI
Nrf2, immune cells and lung cancer$350,410
R01 · FY2021 · CA · contact PI
Nrf2, immune cells and lung cancer$350,290
R01 · FY2020 · CA · contact PI
Nrf2, immune cells and lung cancer$364,001
R01 · FY2019 · CA · contact PI